Key result
Cochrane protocol outlines evaluation of renin inhibitors versus ARBs for primary hypertension.
Why the study?
The efficacy and safety of renin inhibitors compared to angiotensin receptor blockers in people with primary hypertension required evaluation.
Population
People with primary hypertension
Comparison
Renin inhibitors vs angiotensin receptor blockers
Design
Protocol for a Cochrane Review (Intervention)
Answers are grounded in this paper and cite their sources.
Current hypertension management unchanged; protocol leaves open comparative efficacy and safety of renin inhibitors versus ARBs pending synthesis.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of renin inhibitors compared to angiotensin receptor blockers in people with primary hypertension.
No takes yet. Share an insight, caveat, or question.
Li et al. (2017) studied this question. Renin inhibitors versus angiotensin receptor blockers for primary hypertension will be evaluated for efficacy and safety in this Cochrane Review protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: